Cryofocus Medtech (Shanghai) Co. Ltd. (06922.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

HKD 423.26M

MomentumView details →

1D Return

−2.74%

YTD Return

−58.72%

RSI (14)

8.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

HKD 423.26M

RSI (14)

8.0

MomentumView details →

1D Return

−2.74%

YTD Return

−58.72%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

Kangfeng Biotech reported interim results for the six months ended June 2026, with revenue down 20.4% year-on-year and net loss narrowing to RMB 15.082 million.7d ago

Similar companies

ClearPoint Neuro, Inc.CLPT 908 Devices Inc.MASS Vincent Medical Holdings Limited01612.HK Pacific Biosciences of California, Inc.PACB Movano Inc.MOVE Sight Sciences, Inc.SGHT Find similar companies →

Latest newsMore news →

Kangfeng Biotech reported interim results for the six months ended June 2026, with revenue down 20.4% year-on-year and net loss narrowing to RMB 15.082 million.7d ago